3 completed, 1 active not recruiting, 1 recruiting. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Corneal Edema: new trials by email Literature Review of Corneal Edema trials Research Report on Corneal Edema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction 150K cells, 500K cells, Placebo - Corneal Edema, Fuchs | Phase 2 | Recruiting | Emmecell | 121 | 2026-10-01 | 2026-10-09 |
| The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK) Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution, Placebo - Pseudophakic Bullous Keratopathy, Glaucoma | Phase 2 / Phase 3 | Completed | University Hospital Dubrava | 50 | 2025-05-12 | 2026-09-09 |
| Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction Cryopreserved AURN001 - Corneal Edema | Phase 2 | Active not recruiting | Aurion Biotech | 25 | 2024-09-16 | 2025-01-28 |
| A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1) AURN001, Corneal Endothelial Cells, Y27632 - Corneal Edema, Corneal Endothelial Dysfunction | Phase 1 / Phase 2 | Completed | Aurion Biotech | 97 | 2023-10-18 | 2025-12-17 |
| A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy Netarsudil Ophthalmic - Corneal Edema | Phase 2 | Completed | Aerie Pharmaceuticals | 40 | 2020-09-17 | 2022-09-15 |
Fuchs' Endothelial Dystrophy (2) · Corneal Endothelial Cell Loss (1) · Corneal Endothelial Dystrophy 1 (1) · Corneal endothelial dystrophy type 2 (1) · Glaucoma (1)
Corneal Diseases (5) · Eye Diseases (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Corneal Dystrophies, Hereditary (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Eye Manifestations (1) · Ocular Hypertension (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1) · Signs and Symptoms (1)
Latanoprost (1) · Y 27632 (1) · netarsudil (1)
Aurion Biotech (2) · Aerie Pharmaceuticals (1) · Emmecell (1) · University Hospital Dubrava (1)
United States (3) · Canada (1) · Croatia (1) · El Salvador (1)
Josip Pavan, MD, PhD (1) · Michelle Senchyna, Ph.D. (1) · Noelia Kunzevitzky, PhD (1)